A Randomized Trial of Ambisome Monotherapy and Combination of Ambisome and Miltefosine for the Treatment of VL in HIV Positive Patients in Ethiopia Followed by Secondary VL Prophylactic Treatment With Pentamidine

Trial Profile

A Randomized Trial of Ambisome Monotherapy and Combination of Ambisome and Miltefosine for the Treatment of VL in HIV Positive Patients in Ethiopia Followed by Secondary VL Prophylactic Treatment With Pentamidine

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Oct 2016

At a glance

  • Drugs Amphotericin B liposomal (Primary) ; Miltefosine
  • Indications Visceral leishmaniasis
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Mar 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov.
    • 17 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 28 Sep 2014 Status changed from not yet recruiting to recruiting, as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top